trial · primary record
Abemaciclib
CDK Gene Mutation
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 50 |
| Primary completion | 2028-06 |
| Primary endpoint | Objective Response Rate in the Brain |
| Registry ID | NCT03994796 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:38.831Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03994796
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Abemaciclib · approval
- Abemaciclib · compound